Penicillin Market: Increase in incidence of infectious diseases to drive the market

Penicillin is a class of antibiotics used in the treatment of bacterial infections. Penicillin antibiotics are bactericidal agents that inhibit the bacterial cell wall synthesis and induce a bacterial autolytic effect. Different types of penicillin antibiotics are available for various types of bacterial infections, each specific to particular bacterial organism. Penicillin is active against various forms of streptococci, Listeria, Neisseria gonorrhoeae, Clostridium, Peptostreptococcus. E. coli, pneumococci, Salmonella, certain strains of staphylococci, and other types of bacteria. These are available in different dosage forms such as tablets, capsules, and powder for injections and suspension. Penicillin is used to treat sexually transmitted diseases, urinary tract infections, pneumonia, ear infections, skin infections, and other bacterial infections.

Read Report Overview -  https://www.transparencymarketresearch.com/penicillin-market.html

Increase in incidence of infectious diseases such as pneumonia, gonorrhea, and syphilis is a major factor driving the global penicillin market. According to the Centers for Disease Control and Prevention (CDC), 101,567 cases of syphilis were reported in the U.S. in 2017, yielding a rate of 31.4 cases per 100,000 population. Moreover, urinary tract infections and other contagious diseases are rising across the globe. This is projected to fuel the demand for penicillin antibiotics in the next few years. Increase in awareness campaigns by government and private organizations for the control of bacterial infectious diseases and rise in investment in research and development activities are the other factors anticipated to boost the growth of the global penicillin market during the forecast period. However, emergence of antibiotic resistance by various species of bacteria and adverse reactions including hypersensitivity reactions, allergic reactions, anaphylaxis, and rashes associated with intake of penicillin are expected to restrain the penicillin market in the near future. Certain strains of staphylococci are resistant to penicillin, making it challenging to treat bacterial infections. 

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59808

The global penicillin market can be segmented based on drug class, route of administration, indication, distribution channel, and region. In terms of drug class, the market can be categorized into natural penicillin, aminopenicillin, beta-lactamase inhibitors, penicillinase-resistant penicillin, and anti-pseudomonal penicillin. Based on route of administration, the global penicillin market can be classified into oral, intravenous, and intramuscular. In terms of indication, the penicillin market can be divided into urinary tract infections, sexually transmitted diseases, meningitis, respiratory tract infections, skin infections, and others. Based on distribution channel, the market can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies. 

Request for Analysis of COVID-19 Impact on Penicillin Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=59808

The global penicillin market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for dominant share of the global market between 2018 and 2026. This is attributed to increase in incidence of sexually transmitted diseases such as gonorrhea and syphilis in the U.S. According to CDC, the country reported 555,608 cases of gonorrhea in 2017, accounting for 171.9 cases per 100,000 population and an increase of 67% since 2013. The market in Europe is expected to grow at a rapid pace during the forecast period. Increase in incidence and mortality rate of infectious diseases including pneumonia in emerging markets such as India and China is likely to drive demand for penicillin antibiotics in the next few years. Favorable government support for raising awareness among people about infectious diseases and rise in the number of antibiotic manufacturers in these countries are anticipated to boost the growth of the penicillin market in Asia Pacific. 

Pre Book Penicillin Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=59808&ltype=S

Key players operating in the global penicillin market are Pfizer, Inc., Merck Co. & Inc., Sanofi Aventis, Astellas Pharma, Inc., Toyama Chemical Co., Ltd, Novartis AG, and GlaxoSmithKline plc. These players have adopted organic and in-organic growth strategies to expand product portfolio and strengthen market foothold.

More Trending Reports by Transparency Market Research:

Cardiac Assist Devices Market Cardiac Assist Devices (CAD) are a type of mechanical pumps that work along with the heart to improve its pumping efficiency and maintain optimum blood flow throughout the body. Cardiac assist devices are used to treat end stage heart failure and are determined by the needs of the individual. 

CEA Antibodies Market Carcinoembryonic antigen (CEA) is a protein usually produced in developing fetus and disappears or is absent in adults. Production of abnormal amount of CEA protein could lead to cancer.

Central Nervous System (CNS) Biomarkers Market Biomarkers are measurable biological indicators that are used to diagnose or predict diseases, examine disease progression, and estimate treatment response. Biomarkers help in understanding the development of chronic diseases, its relationship with environmental chemicals, and identify subjects who are at high risk of developing disease.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Back to news